Predominance of HIV-1 subtype A and D infections in Uganda

被引:34
作者
Hu, DJ
Baggs, J
Downing, RG
Pieniazek, D
Dorn, J
Fridlund, C
Biryahwaho, B
Sempala, SDK
Rayfield, MA
Dondero, TJ
Lal, R
机构
[1] Ctr Dis Control & Prevent, Int Activities Branch, Div HIV AIDS Prevent, NCHSTP, Atlanta, GA 30333 USA
[2] State Washington, Dept Labor & Ind, Washington, DC USA
[3] Ctr Dis Control & Prevent Res Collaborat, Uganda Virus Res Inst, Entebbe, Uganda
关键词
D O I
10.3201/eid0606.000609
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To better characterize the virus isolates associated with the HIV-1 epidemic in Uganda, 100 specimens from HIV-1-infected persons were randomly selected from each of two periods from late 1994 to late 1997. The 200 specimens were classified into HIV-1 subtypes by sequence-based phylogenetic analysis of the envelope (env) gp41 region; 98 (49%) were classified as env subtype A, 96 (48%) as D, 5 (2.5%) as C, and 1 was not classified as a known env subtype. Demographic characteristics of persons infected with the two principal HIV-1 subtypes, A and D, were Very similar, and the proportion of either subtype did not differ significantly between early and later periods. Our systematic characterization of the HIV-1 epidemic in Uganda over an almost 3-year period documented that the distribution and degree of genetic diversity of the HIV subtypes A and D are very similar and did not change appreciably over that time.
引用
收藏
页码:609 / 615
页数:7
相关论文
共 26 条
[1]   UGANDAN HIV-1 V3 LOOP SEQUENCES CLOSELY RELATED TO THE UNITED-STATES EUROPEAN CONSENSUS [J].
ALBERT, J ;
FRANZEN, L ;
JANSSON, M ;
SCARLATTI, G ;
KATAAHA, PK ;
KATABIRA, E ;
MUBIRO, F ;
RYDAKER, M ;
ROSSI, P ;
PETTERSSON, U ;
WIGZELL, H .
VIROLOGY, 1992, 190 (02) :674-681
[2]   Increasing diversity of HIV-1(M) serotypes in French blood donors over a 10-year period (1985-1995) [J].
Barin, F ;
Courouce, AM ;
Pillonel, J ;
Buzelay, L ;
Baudelot, J ;
Botte, C ;
Chamaret, S ;
Durand, F ;
Elghouzzi, MH ;
Lemaire, JM ;
Maisonneuve, P ;
Maniez, M ;
Moncharmont, P ;
Noel, L ;
North, ML ;
Piquet, Y ;
Rouzioux, C ;
Smilovici, W ;
Tirtaine, C .
AIDS, 1997, 11 (12) :1503-1508
[3]   Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda [J].
Brennan, CA ;
Lund, JK ;
Golden, A ;
Yamaguchi, J ;
Vallari, AS ;
Phillips, JF ;
Kataaha, PK ;
Jackson, JB ;
Devare, SG .
AIDS, 1997, 11 (15) :1823-1832
[4]   PRESENCE OF MULTIPLE GENETIC SUBTYPES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRUSES IN UGANDA [J].
BRUCE, C ;
CLEGG, C ;
FEATHERSTONE, A ;
SMITH, J ;
BIRYAHAWAHO, B ;
DOWNING, R ;
ORAM, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1543-1550
[5]   Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection [J].
Dorn, J ;
Masciotra, S ;
Yang, CF ;
Downing, R ;
Biryahwaho, B ;
Mastro, TD ;
Nkengasong, J ;
Pieniazek, D ;
Rayfield, MA ;
Hu, DJ ;
Lal, RB .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :773-780
[6]   Genetic characterization and phylogenetic analysis of HIV-1 subtype C from Uganda [J].
Downing, R ;
Pieniazek, D ;
Hu, DJ ;
Biryahwaho, B ;
Fridlund, C ;
Rayfield, MA ;
Sempala, SDK ;
Lal, RB .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (08) :815-819
[7]   What role does HIV-1 subtype play in transmission and pathogenesis?: An epidemiological perspective [J].
Hu, DJ ;
Buvé, A ;
Baggs, J ;
van der Groen, G ;
Dondero, TJ .
AIDS, 1999, 13 (08) :873-881
[8]   The emerging genetic diversity of HIV - The importance of global surveillance for diagnostics, research, and prevention [J].
Hu, DJ ;
Dondero, TJ ;
Rayfield, MA ;
George, JR ;
Schochetman, G ;
Jaffe, HW ;
Luo, CC ;
Kalish, ML ;
Weniger, BG ;
Pau, CP ;
Schable, CA ;
Curran, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :210-216
[9]   The puzzle of HIV-1 subtypes in Africa [J].
Janssens, W ;
Buve, A ;
Nkengasong, JN .
AIDS, 1997, 11 (06) :705-712
[10]   THE EVOLVING MOLECULAR EPIDEMIOLOGY OF HIV-1 ENVELOPE SUBTYPES IN INJECTING DRUG-USERS IN BANGKOK, THAILAND - IMPLICATIONS FOR HIV VACCINE TRIALS [J].
KALISH, ML ;
BALDWIN, A ;
RAKTHAM, S ;
WASI, C ;
LUO, CC ;
SCHOCHETMAN, G ;
MASTRO, TD ;
YOUNG, N ;
VANICHSENI, S ;
RUBSAMENWAIGMANN, H ;
VONBRIESEN, H ;
MULLINS, JI ;
DELWART, E ;
HERRING, B ;
ESPARZA, J ;
HEYWARD, WL ;
OSMANOV, S .
AIDS, 1995, 9 (08) :851-857